Literature DB >> 12866030

Imbalances of chemokines, chemokine receptors and cytokines in Hodgkin lymphoma: classical Hodgkin lymphoma vs. Hodgkin-like ATLL.

Koichi Ohshima1, Kennosuke Karube, Makoto Hamasaki, Hiroaki Suefuji, Takeshi Tutiya, Takahiro Yamaguchi, Junji Suzumiya, Masahiro Kikuchi.   

Abstract

Classical Hodgkin lymphoma (HL) is characterized by the presence of Hodgkin and Reed-Sternberg cells (H&RS) and a prominent lymphocytic infiltration. We previously reported Hodgkin-like adult T-cell leukemia/lymphoma (HL-like ATLL) (new WHO classification). Various CXC and CC chemokines are expressed on H&RS cells and the relationships between chemokines and the chemokine receptor (R) are thought to be important for selectivity of local immunity of Th1 and Th2 T cells. To clarify the role of T-cell immunity in classical HL and Hodgkin-like ATLL, we performed gene expression profiling (chemokine, chemokine R and cytokine DNA chips) in 12 cases [classical HL, 8 cases [mixed cellularity (MC) type, 4; nodular sclerosis (NS) type, 4]; Hodgkin-like ATLL, 4 cases] and immunohistochemical staining in 29 cases (MC, 10; NS, 10; Hodgkin-like ATLL, 9). EBV-infected H&RS cells were detected in 9 of 10 cases of HL MC, 5 of 9 of HL-like ATLL and 2 of 10 HL NS. T-cell-directed chemokine thymus- and activation-regulated chemokine (TARC)- and/or macrophage-derived chemokine (MDC)-positive H&RS cells were detected in all 20 cases of HL MC and HL NS but only in 5 of 9 cases of HL-like ATLL. Interferon-gamma-inducible protein-10 (IP10)- and monokine induced by interferon-gamma (MIG)-positive H&RS cells were detected in all 10 HL MC but only in 5 of 10 cases of HL NS and 2 of 9 cases of HL-like ATLL. However, 2 of 5 cases of HL-like ATLL with EBV infection and 2 of 2 HL NS with EBV had IP10/MIG-positive H&RS cells. The chemokine expressions in H&RS cells seemed to be associated with EBV infection rather than histologic subtypes. In the DNA chip expression analysis, classical HL and HL-like ATLL had a mixed Th1/Th2-type profile, and HL MC (EBV-positive) and HL NS (EBV-negative) were differentially clustered. However, 2 cases of HL-like ATLL clustered with HL MS and the other 2 cases of HL-like ATLL clustered with HL NS. The former HL-like ATLL had EBV infection in H&RS cells, whereas the latter did not have EBV infection. This finding also suggests that EBV might influence local expression of chemokines rather than HL subtypes. Our results indicate that local immunologic disorder or imbalance appears to influence the formation of H&RS cells and that in HL-like ATLL, HTLV-1 infection might not be necessary for H&RS cell formation. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12866030     DOI: 10.1002/ijc.11301

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Adult T-cell leukemia/lymphoma with Epstein-Barr virus-positive Hodgkin-like cells.

Authors:  Girish Venkataraman; Jonathan Berkowitz; John C Morris; John E Janik; Mark A Raffeld; Stefania Pittaluga
Journal:  Hum Pathol       Date:  2011-02-11       Impact factor: 3.466

2.  Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma.

Authors:  Naoko Asano; Ritsuro Suzuki; Koichi Ohshima; Yoshitoyo Kagami; Fumihiro Ishida; Tadashi Yoshino; Hiroshi Ogawa; Yasuo Morishima; Shigeo Nakamura
Journal:  Int J Hematol       Date:  2010-03-09       Impact factor: 2.490

3.  Cytotoxic molecule-positive classical Hodgkin's lymphoma: a clinicopathological comparison with cytotoxic molecule-positive peripheral T-cell lymphoma of not otherwise specified type.

Authors:  Naoko Asano; Tomohiro Kinoshita; Jun-Ichi Tamaru; Koichi Ohshima; Tadashi Yoshino; Nozomi Niitsu; Norifumi Tsukamoto; Kaoru Hirabayashi; Koji Izutsu; Masafumi Taniwaki; Yasuo Morishima; Shigeo Nakamura
Journal:  Haematologica       Date:  2011-08-22       Impact factor: 9.941

Review 4.  Hodgkin disease and the role of the immune system.

Authors:  Alana A Kennedy-Nasser; Patrick Hanley; Catherine M Bollard
Journal:  Pediatr Hematol Oncol       Date:  2011-04       Impact factor: 1.969

5.  cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours.

Authors:  K Karube; K Nabeshima; M Ishiguro; M Harada; H Iwasaki
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

6.  Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist.

Authors:  Alina Nicolae; Stefania Pittaluga; Girish Venkataraman; Anahi Vijnovich-Baron; Liqiang Xi; Mark Raffeld; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2013-06       Impact factor: 6.394

Review 7.  Hodgkin lymphoma: an update on its biology with new insights into classification.

Authors:  Haresh Mani; Elaine S Jaffe
Journal:  Clin Lymphoma Myeloma       Date:  2009-06

Review 8.  The Microenvironment in Epstein-Barr Virus-Associated Malignancies.

Authors:  Geok Wee Tan; Lydia Visser; Lu Ping Tan; Anke van den Berg; Arjan Diepstra
Journal:  Pathogens       Date:  2018-04-13

9.  Hodgkin-like adult T-cell leukemia/lymphoma that developed during the follow-up of HTLV-1 associated myelopathy/tropical spastic paraparesis.

Authors:  Yosuke Nakaya; Masahiro Yoshida; Minako Tsutsumi; Hoyuri Fuseya; Mirei Horiuchi; Takuro Yoshimura; Yoshiki Hayashi; Takafumi Nakao; Ki-Ryang Koh; Daisuke Niino; Takeshi Inoue; Takahisa Yamane
Journal:  J Clin Exp Hematop       Date:  2019-08-08

Review 10.  Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics.

Authors:  Daniel J García-Domínguez; Lourdes Hontecillas-Prieto; Natalia Palazón-Carrión; Carlos Jiménez-Cortegana; Víctor Sánchez-Margalet; Luis de la Cruz-Merino
Journal:  Cancers (Basel)       Date:  2022-03-13       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.